GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (LSE:DDDD) » Definitions » YoY EPS Growth

4d pharma (LSE:DDDD) YoY EPS Growth : -133.33% (As of Dec. 2021)


View and export this data going back to 2014. Start your Free Trial

What is 4d pharma YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. 4d pharma's YoY EPS Growth for the quarter that ended in Dec. 2021 was -133.33%.

4d pharma's Earnings per Share (Diluted) for the six months ended in Dec. 2021 was £-0.20.

4d pharma YoY EPS Growth Historical Data

The historical data trend for 4d pharma's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4d pharma YoY EPS Growth Chart

4d pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
YoY EPS Growth
Get a 7-Day Free Trial -106.58 -25.48 10.91 35.04 -39.47

4d pharma Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.27 22.95 48.21 17.73 -133.33

4d pharma YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

4d pharma's YoY EPS Growth for the fiscal year that ended in Dec. 2021 is calculated as:

YoY EPS Growth (A: Dec. 2021 )
=(Earnings per Share (Diluted) (A: Dec. 2021 )-Earnings per Share (Diluted) (A: Dec. 2020 ))/ | Earnings per Share (Diluted) (A: Dec. 2020 ) |
=(-0.318--0.228)/ | -0.228 |
=-39.47 %

4d pharma's YoY EPS Growth for the quarter that ended in Dec. 2021 is calculated as:

YoY EPS Growth (Q: Dec. 2021 )
=(Earnings per Share (Diluted) (Q: Dec. 2021 )-Earnings per Share (Diluted) (Q: Dec. 2020 )) / | Earnings per Share (Diluted) (Q: Dec. 2020 )) |
=(-0.203--0.087)/ | -0.087 |
=-133.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4d pharma YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of 4d pharma's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

4d pharma (LSE:DDDD) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (LSE:DDDD) » Definitions » YoY EPS Growth
Comparable Companies
LSE:4BB LSE:C4XD LSE:ONC LSE:SNG LSE:APTA LSE:OKYO LSE:SBTX LSE:OBI LSE:FUM LSE:DEST OCSE:NOVO B ASX:CSL REGN VRTX MRNA XKRX:207940 BNTX HKSE:02269 SGEN SZSE:300122
Traded in Other Exchanges
N/A
Address
9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ
Website
https://www.4dpharmaplc.com
4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.

4d pharma (LSE:DDDD) Headlines

No Headlines